These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15640760)

  • 1. Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism.
    Hayakawa K; Mishima K; Abe K; Hasebe N; Takamatsu F; Yasuda H; Ikeda T; Inui K; Egashira N; Iwasaki K; Fujiwara M
    Neuroreport; 2004 Oct; 15(15):2381-5. PubMed ID: 15640760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance.
    Hayakawa K; Mishima K; Nozako M; Ogata A; Hazekawa M; Liu AX; Fujioka M; Abe K; Hasebe N; Egashira N; Iwasaki K; Fujiwara M
    Neuropharmacology; 2007 Mar; 52(4):1079-87. PubMed ID: 17320118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism.
    Hayakawa K; Mishima K; Nozako M; Hazekawa M; Irie K; Fujioka M; Orito K; Abe K; Hasebe N; Egashira N; Iwasaki K; Fujiwara M
    J Neurochem; 2007 Sep; 102(5):1488-1496. PubMed ID: 17437545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.
    Hayakawa K; Mishima K; Nozako M; Hazekawa M; Ogata A; Fujioka M; Harada K; Mishima S; Orito K; Egashira N; Iwasaki K; Fujiwara M
    Life Sci; 2007 Mar; 80(16):1466-71. PubMed ID: 17289082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia.
    Muthian S; Rademacher DJ; Roelke CT; Gross GJ; Hillard CJ
    Neuroscience; 2004; 129(3):743-50. PubMed ID: 15541895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
    Fride E; Ponde D; Breuer A; Hanus L
    Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.
    Roser P; Vollenweider FX; Kawohl W
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):208-19. PubMed ID: 20218784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of hypothermia and CB1 receptor activation to protective effects of TAK-937, a cannabinoid receptor agonist, in rat transient MCAO model.
    Suzuki N; Suzuki M; Hamajo K; Murakami K; Tsukamoto T; Shimojo M
    PLoS One; 2012; 7(7):e40889. PubMed ID: 22815855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
    Taffe MA; Creehan KM; Vandewater SA
    Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism.
    Mishima K; Hayakawa K; Abe K; Ikeda T; Egashira N; Iwasaki K; Fujiwara M
    Stroke; 2005 May; 36(5):1077-82. PubMed ID: 15845890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism.
    Hayakawa K; Mishima K; Irie K; Hazekawa M; Mishima S; Fujioka M; Orito K; Egashira N; Katsurabayashi S; Takasaki K; Iwasaki K; Fujiwara M
    Neuropharmacology; 2008 Dec; 55(8):1280-6. PubMed ID: 18634812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys.
    Taffe MA
    Neuroscience; 2012 Jan; 201():125-33. PubMed ID: 22138434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of milk ingestion and growth after administration of a neutral cannabinoid CB1 receptor antagonist on the first postnatal day in the mouse.
    Fride E; Braun H; Matan H; Steinberg S; Reggio PH; Seltzman HH
    Pediatr Res; 2007 Nov; 62(5):533-6. PubMed ID: 17805201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A
    Aso E; Fernández-Dueñas V; López-Cano M; Taura J; Watanabe M; Ferrer I; Luján R; Ciruela F
    Mol Neurobiol; 2019 Aug; 56(8):5382-5391. PubMed ID: 30610611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain.
    Erdozain AM; Diez-Alarcia R; Meana JJ; Callado LF
    Biochem Pharmacol; 2012 Jan; 83(2):260-8. PubMed ID: 22093909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.
    Capasso R; Borrelli F; Aviello G; Romano B; Scalisi C; Capasso F; Izzo AA
    Br J Pharmacol; 2008 Jul; 154(5):1001-8. PubMed ID: 18469842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant.
    Gerdeman GL; Schechter JB; French ED
    Neuropsychopharmacology; 2008 Oct; 33(11):2747-59. PubMed ID: 18059436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.
    Huestis MA; Gorelick DA; Heishman SJ; Preston KL; Nelson RA; Moolchan ET; Frank RA
    Arch Gen Psychiatry; 2001 Apr; 58(4):322-8. PubMed ID: 11296091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.